Comparison of the metabolic and hormonal effects of two oral contraceptives in women with polycystic ovary syndrome (PCOS) for a period of two years follow-up.

Completed

• Conditions: Polycystic ovary syndrome; Contraception; Reproductive Health and Childbirth - Contraception; Reproductive Health and Childbirth - Other reproductive health and childbirth disorders; Metabolic and Endocrine - Other metabolic disorders

• Registration Number: ACTRN12614000722695
• Lead Sponsor: Recep Yildizhan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-07-08
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 106

Inclusion Criteria

Polycystic ovary syndrome

Exclusion Criteria

The subjects took no medications (oral contraceptives, glucocorticoids, antiandrogens, insulin sensitizers, ovulation induction agents, or antiobesity drugs) that could affect the biochemical profile and metabolic variables for at least 6 months before entering the study. The exclusion criteria included Cushing’s syndrome, congenital adrenal hyperplasia, hyperprolactinemia, thyroid dysfunction, virilizing tumors, glucose intolerence or diabetes mellitus, hepatic dysfunction, renal dysfunction, hypertension and any contraindications for the use of combined oral contraceptives.

Study & Design

• Study Type: Interventional
• Study Design: Not specified